NewEdge Advisors LLC Has $19.88 Million Position in CME Group Inc. $CME

Key Points

• NewEdge Advisors increased its CME Group stake by 12.9% in the first quarter, holding 67,317 shares valued at approximately $19.88 million. Institutional investors collectively own 87.75% of the company.
• Analyst sentiment is mixed: 11 analysts rate CME Group a Buy, four a Hold and three a Sell, resulting in a consensus Hold rating and an average price target of $291.81.
• CME Group beat quarterly expectations with $2.99 EPS and $1.71 billion in revenue, while declaring a quarterly dividend of $1.30 per share, equivalent to a 2.0% yield.

NewEdge Advisors LLC raised its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 12.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 67,317 shares of the financial services provider's stock after acquiring an additional 7,672 shares during the quarter. NewEdge Advisors LLC's holdings in CME Group were worth $19,882,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. First Nebraska Trust Co acquired a new stake in shares of CME Group during the 1st quarter worth about $577,000. Keel Point LLC boosted its position in CME Group by 3.6% in the first quarter. Keel Point LLC now owns 1,510 shares of the financial services provider's stock valued at $446,000 after buying an additional 52 shares in the last quarter. Groupama Asset Managment grew its stake in CME Group by 16.2% during the first quarter. Groupama Asset Managment now owns 268,871 shares of the financial services provider's stock worth $79,411,000 after buying an additional 37,526 shares during the last quarter. Segall Bryant & Hamill LLC bought a new stake in CME Group during the first quarter worth about $2,810,000. Finally, BankChampaign National Association acquired a new stake in shares of CME Group during the first quarter worth approximately $275,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on CME shares. Morgan Stanley lifted their target price on shares of CME Group from $324.00 to $330.00 and gave the company an "overweight" rating in a research note on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft dropped their price target on CME Group from $342.00 to $322.00 and set a "buy" rating for the company in a report on Thursday, April 23rd. Wall Street Zen downgraded CME Group from a "sell" rating to a "strong sell" rating in a research report on Saturday, August 1st. JPMorgan Chase & Co. boosted their price objective on CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a research note on Thursday, July 23rd. Finally, TD Cowen decreased their target price on CME Group from $323.00 to $273.00 and set a "buy" rating on the stock in a report on Monday, June 22nd. Eleven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $291.81.

Insider Activity at CME Group

In other news, Director William R. Shepard acquired 325 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the company's stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of CME Group stock opened at $263.66 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $94.81 billion, a P/E ratio of 22.36, a P/E/G ratio of 3.08 and a beta of 0.23. The firm has a 50 day simple moving average of $249.24 and a 200 day simple moving average of $280.78. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business's revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.96 EPS. Sell-side analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio is 44.11%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source